Myomectomy During CS: A Retrospective Cohort Study

To evaluate the value of myomectomy during delivery by cesarean section (CS) in pregnant women with uterine fibroids.

Completed

Looking for future studies?

Key information

Conditions

Cesarean Section Leiomyoma Neoplasms Neoplasms by Histologic Type Neoplasms, Connective and Soft Tissue Neoplasms, Muscle Tissue Uterine Fibroid

Age range

18 year–41 year

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women who underwent elective CS with presence of uterine fibroid during the index pregnancy documented antenatal and at surgery

Exclusion criteria

Antepartum hemorrhage
Blood diseases or bleeding tendencies.
Medical conditions complicating pregnancy.
Performed another surgical procedure at CS other than myomectomy.

Treatment and study plan

Myomectomy

Procedure

Surgical removal of uterine fibroid

Primary outcomes

Deficit in hemoglobin level

Time frame: 24 hours

Preoperative hemoglobin minus postoperative hemoglobin level (in gm/dl)

Secondary outcomes

Operative time

Time frame: 3 hours

Time to complete the procedure
Postoperative hospital stay period

Time frame: 7 days

Time from the end of operation to discharge from hospital

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Myomectomy During Cesarean Section: A Retrospective Cohort Study

Important dates

Study start: 2015
Primary completion: 2019
Study completion: 2019
First posted: Sep 1, 2017
Registry last updated: Sep 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed